Joseph Scheeren

Joseph Scheeren has been a member of our board of directors since March 2021. Dr. Scheeren most recently served as President and Chief Executive Officer of Critical Path Institute (C-Path), a non-profit organization that validates tools to speed up drug development in the pre-competitive space.

Prior to joining C-Path, Dr. Scheeren served as Senior Vice President, Head of Global Regulatory Affairs at Bayer Pharmaceuticals, bringing a significant number of novel products to the global market in various therapeutic areas, and numerous executive positions at Aventis Pharmaceuticals, Roussel UCLAF, Ares Serono and Les Laboratoires Servier. He is the current Chairman of the Fellows of the Drug Information Association and serves on several non-profit boards of directors. Dr. Scheeren is a lecturer at Yale University and an adjunct Professor at Peking University. He is also a member of the Forum on Drug Discovery, Development and Translation of the National Academy of Sciences and a foreign member of the “Academie Nationale de Pharmacie” in France. Dr. Scheeren studied pharmacy at the University of Leiden.